HR Execs on the Move

Anavasi Diagnostics

www.anavasi.com

 
Anavasi Diagnostics is a medical technology company focused on saving lives by developing novel molecular diagnostic testing using a proprietary patent-pending reverse transcriptase methodology. It was founded by world-leading university researchers, top medical device and clinical diagnostics engineering and design executives, manufacturing experts and a former Microsoft software veteran. Throughout their careers, the team has altogether been responsible for the introduction of more than forty medical/diagnostic products and over 350 peer-reviewed research publications.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.anavasi.com
  • 4000 Mason Road
    Seattle, WA USA 98195
  • Phone: 888.262.8274

Executives

Name Title Contact Details
Scott Robitaille
Vice President of Sales and Marketing Profile

Similar Companies

VIRTUAL IMAGING

VIRTUAL IMAGING is a Deerfield Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Spartan Bioscience

Spartan Bioscience Inc. is a Nepean, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

BIOCARDIA

BIOCARDIA is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

NeuroOne Incorporated

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. Today, our attention is on the development and commercialization of patented thin-film, cortical electrode technology for intracranial electroencephalography (iEEG) and depth electrodes for stereoelectroencephalography (sEEG) recording of brain activity. The products currently available in these categories have significant limitations such as low recording resolution and high risk of infection. NeuroOne believes our technology can address these unmet needs upon initial commercialization with pipeline technology to advance the field by enabling minimally invasive techniques and all-in-one diagnostic and therapeutic options. While our initial focus is Epilepsy, future applications in Parkinson`s disease, Essential tremors, and Dystonia are within sight. NeuroOne technologies will be presented to a well-defined market, eager for the advancement they bring. There are 188 hospital centers licensed to perform epilepsy surgical procedures in the U.S. The current addressable market opportunity for is approximately $525.6 million. As more patients choose the minimally invasive procedures made available by NeuroOne technology, the future opportunity is estimated to be approximately $14.9 billion with full market penetration.

Bioderm Sciences

Bioderm Sciences is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.